{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:58:21Z","timestamp":1792486701379,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["Grant 2021M701089"],"award-info":[{"award-number":["Grant 2021M701089"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["Grant No. 22A350002"],"award-info":[{"award-number":["Grant No. 22A350002"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["212300410110"],"award-info":[{"award-number":["212300410110"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300420047"],"award-info":[{"award-number":["232300420047"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["222102310402"],"award-info":[{"award-number":["222102310402"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","award":["222102310216"],"award-info":[{"award-number":["222102310216"]}],"id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Platinum-drugs based chemotherapy in clinic increases the potency of tumor cells to produce M2 macrophages, thus leading to poor anti-metastatic activity and immunosuppression. Lysosome metabolism is critical for cancer cell migration and invasion, but how it promotes antitumor immunity in tumours and macrophages is poorly understood and the underlying mechanisms are elusive. The present study aimed to explore a synergistic strategy to dismantle the immunosuppressive microenvironment of tumours and metallodrugs discovery by using the herent metabolic plasticity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Naphplatin was prepared by coordinating an active alkaline moiety to cisplatin, which can regulate the lysosomal functions. Colorectal carcinoma cells were selected to perform the in vivo biological assays. Blood, tumour and spleen tissues were collected and analyzed by flow cytometry to further explore the relationship between anti-tumour activity and immune cells. Transformations of bone marrow derived macrophage (BMDM) and M2-BMDM to the M1 phenotype was confirmed after treatment with naphplatin. The key mechanisms of lysosome-mediated mucolipin-1(Mcoln1) and mitogen-activated protein kinase (MAPK) activation in M2 macrophage polarization have been unveiled. RNA sequencing (RNA-seq) was used to further explore the key mechanism underlying high-mobility group box 1(HMGB1)-mediated Cathepsin L(CTSL)-lysosome function blockade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We demonstrated that naphplatin induces divergent lysosomal metabolic programs and reprograms macrophages in tumor cells to terminate the vicious tumour-associated macrophages (TAMs)-MDSCs-Treg triangle. Mechanistically, macrophages treated with naphplatin cause lysosome metabolic activation by triggering Ca<jats:sup>2+<\/jats:sup> release <jats:italic>via<\/jats:italic> Mcoln1, which induces the activation of p38 and nuclear factor-\u03baB (NF-\u03baB) and finally results in polarizing M2 macrophages. In contrast, HMGB1-mediated lysosome metabolic blockade in cancer cells is strongly linked to antitumor effects by promoting cytoplasmic translocation of HMGB1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study reveals the crucial strategies of macrophage-based metallodrugs discovery that are able to treat both immunologically \u201chot\u201d and \u201ccold\u201d cancers. Different from traditional platinum-based antitumour drugs by inhibition of DNAs, we also deliver a strong antitumour strategy by targeting lysosome to induce divergent metabolic programs in macrophages and tumours for cancer immunotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-023-02768-0","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T02:01:34Z","timestamp":1691114494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lysosome blockade induces divergent metabolic programs in macrophages and tumours for cancer immunotherapy"],"prefix":"10.1186","volume":"42","author":[{"given":"Jing","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochen","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng George","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"2768_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"T Gajewski","year":"2013","unstructured":"Gajewski T, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014\u201322.","journal-title":"Nat Immunol"},{"key":"2768_CR2","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1158\/0008-5472.CAN-17-1340","volume":"77","author":"KD Moynihan","year":"2017","unstructured":"Moynihan KD, Irvine DJ. Roles for Innate Immunity in Combination Immunotherapies. Cancer Res. 2017;77:5215\u201321.","journal-title":"Cancer Res"},{"key":"2768_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021;21:37\u201350.","journal-title":"Nat Rev Cancer"},{"key":"2768_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.214210","volume":"449","author":"P Kun","year":"2021","unstructured":"Kun P, Bing-Bing L, Wenting L, Zong-Wan M. What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives. Coord Chem Rev. 2021;449: 214210.","journal-title":"Coord Chem Rev"},{"key":"2768_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.12.024","volume":"472","author":"W Liu","year":"2020","unstructured":"Liu W, Wang W, Wang X, Xu C, Zhang N, Di W. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis. Cancer Lett. 2020;472:59\u201369.","journal-title":"Cancer Lett"},{"key":"2768_CR6","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1158\/0008-5472.CAN-12-3542","volume":"73","author":"EM Dijkgraaf","year":"2013","unstructured":"Dijkgraaf EM, et al. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res. 2013;73:2480\u201392.","journal-title":"Cancer Res"},{"key":"2768_CR7","doi-asserted-by":"crossref","unstructured":"Mai FY, He P. et al. Caspase-3-mediated GSDME activation contributes to cisplatin- and doxorubicin-induced secondary necrosis in mouse macrophages. Cell Prolif. 2019; 52:e12663.","DOI":"10.1111\/cpr.12663"},{"key":"2768_CR8","doi-asserted-by":"crossref","unstructured":"Zheng P, Chen L. et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017; 36:53.","DOI":"10.1186\/s13046-017-0528-y"},{"key":"2768_CR9","doi-asserted-by":"crossref","unstructured":"Huang WC, Kuo KT. et al. Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src\/CD155\/MIF functional pathway. J Exp Clin Cancer Res. 2019; 38:180.","DOI":"10.1186\/s13046-019-1166-3"},{"key":"2768_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, et al. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"2768_CR11","doi-asserted-by":"crossref","unstructured":"Jaynes JM, Sable R. et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med. 2020; 12(530):eaax6337.","DOI":"10.1126\/scitranslmed.aax6337"},{"key":"2768_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17:97\u2013111.","journal-title":"Nat Rev Immunol"},{"key":"2768_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41:49\u201361.","journal-title":"Immunity"},{"key":"2768_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1084\/jem.20150295","volume":"212","author":"A Mantovani","year":"2015","unstructured":"Mantovani A, Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med. 2015;212:435\u201345.","journal-title":"J Exp Med"},{"key":"2768_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41:21\u201335.","journal-title":"Immunity"},{"key":"2768_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887\u2013904.","journal-title":"Nat Rev Drug Discov"},{"key":"2768_CR17","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869\u201383.","journal-title":"Oncogene"},{"key":"2768_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17:528\u201342.","journal-title":"Nat Rev Cancer"},{"key":"2768_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre C, Fraldi A, Medina DL, Ballabio A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol. 2013;14:283\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2768_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13045-021-01087-1","volume":"14","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. Role of lysosomes in physiological activities, diseases, and therapy. J Hematol Oncol. 2021;14:79.","journal-title":"J Hematol Oncol"},{"key":"2768_CR21","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1158\/2159-8290.CD-17-0741","volume":"7","author":"VW Rebecca","year":"2017","unstructured":"Rebecca VW, Nicastri MC, et al. A unified approach to targeting the lysosome\u2019s degradative and growth signaling roles. Cancer Discov. 2017;7:1266\u201383.","journal-title":"Cancer Discov"},{"key":"2768_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1021\/acs.jmedchem.5b01399","volume":"59","author":"Z Al-Eisawi","year":"2016","unstructured":"Al-Eisawi Z, Stefani C, et al. Novel mechanism of cytotoxicity for the selective selenosemicarbazone, 2-acetylpyridine 4,4-dimethyl-3-selenosemicarbazone (Ap44mSe): lysosomal membrane permeabilization. J Med Chem. 2016;59:294\u2013312.","journal-title":"J Med Chem"},{"key":"2768_CR23","doi-asserted-by":"publisher","first-page":"42471","DOI":"10.1021\/acsami.7b10258","volume":"9","author":"FX Wang","year":"2017","unstructured":"Wang FX, Chen MH, et al. Dual functions of cyclometalated iridium(iii) complexes: anti-metastasis and lysosome-damaged photodynamic therapy. ACS Appl Mater Interfaces. 2017;9:42471\u201381.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2768_CR24","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1021\/acs.jmedchem.7b00433","volume":"60","author":"J Ma","year":"2017","unstructured":"Ma J, Wang Q, Huang Z, Yang X, Nie Q, Hao W, Wang PG, Wang X. Glycosylated platinum (IV) complexes as substrates for glucose transporters (GLUTs) and Organic Cation Transporters (OCTs) exhibited cancer targeting and human serum albumin binding properties for drug delivery. J Med Chem. 2017;60:5736\u201348.","journal-title":"J Med Chem"},{"key":"2768_CR25","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1021\/acs.jmedchem.9b01641","volume":"62","author":"H Liu","year":"2019","unstructured":"Liu H, Ma J, et al. Polyamine-Based Pt(IV) Prodrugs as substrates for polyamine transporters preferentially accumulate in cancer metastases as dna and polyamine metabolism dual-targeted antimetastatic agents. J Med Chem. 2019;62:11324\u201334.","journal-title":"J Med Chem"},{"key":"2768_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113469","volume":"221","author":"J Ma","year":"2021","unstructured":"Ma J, Li L, Yue K, Zhang Z, Su S, Chen Y, Yu L, Zhang P, Ma R, Li Y, Ma Y, Jia H, Wang C, Wang J, Xie S. Eur J Med Chem. 2021;221: 113469.","journal-title":"Eur J Med Chem"},{"key":"2768_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejmech.2017.01.032","volume":"128","author":"J Ma","year":"2017","unstructured":"Ma J, Yang X, Hao W, Huang Z, Wang X, Wang PG. Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo. Eur J Med Chem. 2017;128:45\u201355.","journal-title":"Eur J Med Chem"},{"key":"2768_CR28","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1021\/acs.jmedchem.6b01846","volume":"60","author":"F Dai","year":"2017","unstructured":"Dai F, Li Q, et al. Design, Synthesis, and Biological Evaluation of Mitochondria-Targeted Flavone-Naphthalimide-Polyamine Conjugates with Antimetastatic Activity. J Med Chem. 2017;60:2071\u201383.","journal-title":"J Med Chem"},{"key":"2768_CR29","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1021\/acs.jmedchem.8b00694","volume":"61","author":"J Li","year":"2018","unstructured":"Li J, Tian R, Ge C, Chen Y, Liu X, Wang Y, Yang Y, Luo W, Dai F, Wang S, Chen S, Xie S, Wang C. Discovery of the Polyamine Conjugate with Benzo[cd]indol-2(1 H)-one as a Lysosome-Targeted Antimetastatic Agent. J Med Chem. 2018;61:6814\u201329.","journal-title":"J Med Chem"},{"key":"2768_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2021.06.015","volume":"519","author":"C Ge","year":"2021","unstructured":"Ge C, Wang Y, et al. Suppression of oxidative phosphorylation and IDH2 sensitizes colorectal cancer to a naphthalimide derivative and mitoxantrone. Cancer Lett. 2021;519:30\u201345.","journal-title":"Cancer Lett"},{"key":"2768_CR31","doi-asserted-by":"crossref","unstructured":"Chen D, Xie J, Fiskesund R. et al. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 2018; 9:873.","DOI":"10.1038\/s41467-018-04169-w"},{"key":"2768_CR32","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1039\/c2cs35467e","volume":"42","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Veale EB, et al. Recent advances in the development of 1,8-naphthalimide based DNA targeting binders, anticancer and fluorescent cellular imaging agents. Chem Soc Rev. 2013;42:1601\u201318.","journal-title":"Chem Soc Rev"},{"key":"2768_CR33","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1021\/acsami.7b14473","volume":"10","author":"P Gopikrishna","year":"2018","unstructured":"Gopikrishna P, Meher N, Iyer PK. Functional 1,8-naphthalimide AIE\/AIEEgens: recent advances and prospects. ACS Appl Mater Interfaces. 2018;10:12081\u2013111.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2768_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147:275\u201392.","journal-title":"Cell"},{"key":"2768_CR35","doi-asserted-by":"crossref","unstructured":"Sonnenschein C, Soto AM. Cancer Metastases: So Close and So Far. J Natl Cancer Inst. 2015; 107:djv236.","DOI":"10.1093\/jnci\/djv236"},{"key":"2768_CR36","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1021\/jacs.0c00221","volume":"142","author":"Z Deng","year":"2020","unstructured":"Deng Z, Wang N, Liu Y, Xu Z, Wang Z, Lau TC, Zhu G. A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism. J Am Chem Soc. 2020;142:7803\u201312.","journal-title":"J Am Chem Soc"},{"key":"2768_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol. 2016;39:1\u20136.","journal-title":"Curr Opin Immunol"},{"key":"2768_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"2768_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13:679\u201392.","journal-title":"Nat Rev Immunol"},{"key":"2768_CR40","doi-asserted-by":"crossref","unstructured":"Shen D, Wang X. et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat Commun. 2012;3:731.","DOI":"10.1038\/ncomms1735"},{"key":"2768_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4161\/auto.8.2.18940","volume":"8","author":"J Huang","year":"2012","unstructured":"Huang J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D, Ni J. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy. 2012;8:275\u20137.","journal-title":"Autophagy"},{"key":"2768_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41419-020-2536-7","volume":"11","author":"B Khambu","year":"2020","unstructured":"Khambu B, Hong H, Liu S, Liu G, Chen X, Dong Z, Wan J, Yin XM. The HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors. Cell Death Dis. 2020;11:333.","journal-title":"Cell Death Dis"},{"key":"2768_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1476-4598-13-165","volume":"13","author":"B Pan","year":"2014","unstructured":"Pan B, Chen D, Huang J, Wang R, Feng B, Song H, Chen L. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol Cancer. 2014;13:165.","journal-title":"Mol Cancer"},{"key":"2768_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2015.08.007","volume":"155","author":"DR Sudhan","year":"2015","unstructured":"Sudhan DR, Siemann DW. Cathepsin L targeting in cancer treatment. Pharmacol Ther. 2015;155:105\u201316.","journal-title":"Pharmacol Ther"},{"key":"2768_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrclinonc.2014.174","volume":"11","author":"SA Rosenberg","year":"2014","unstructured":"Rosenberg SA. Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment. Nat Rev Clin Oncol. 2014;11:630\u20132.","journal-title":"Nat Rev Clin Oncol"},{"key":"2768_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O'Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16:151\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"2768_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","volume":"3","author":"MJ Lin","year":"2022","unstructured":"Lin MJ, Svensson-Arvelund J, Lubitz GS, Marabelle A, Melero I, Brown BD, Brody JD. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3:911\u201326.","journal-title":"Nat Cancer."},{"key":"2768_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19:775\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"2768_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","volume":"19","author":"MJ Pittet","year":"2022","unstructured":"Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol. 2022;19:402\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"2768_CR50","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/0008-5472.CAN-13-1265","volume":"74","author":"Y Ma","year":"2014","unstructured":"Ma Y, Mattarollo SR, Adjemian S. CCL2\/CCR2-dependent recruitment of functional antigenpresenting cells into tumors upon chemotherapy. Cancer Res. 2014;74:436\u201345.","journal-title":"Cancer Res"},{"key":"2768_CR51","doi-asserted-by":"publisher","first-page":"E2646","DOI":"10.1073\/pnas.1604268113","volume":"113","author":"JT Sockolosky","year":"2016","unstructured":"Sockolosky JT, Dougan M, Ingram JR. Durable antitumor responses to CD47 blockade require adaptive immune stimulation. Proc Natl Acad Sci. 2016;113:E2646\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"2768_CR52","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41467-018-03225-9","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Xie J, Fiskesund R, Dong W, Liang X, Lv J, Jin X, Liu J, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Tang K, Ma J, Liu Y, Huang B. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 2018;9:873.","journal-title":"Nat Commun"},{"key":"2768_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jmcb\/mjt022","volume":"5","author":"H Appelqvist","year":"2013","unstructured":"Appelqvist H, Waster P, Kagedal K, Ollinger K. The lysosome: from waste bag to potential therapeutic target. J Mol Cell Biol. 2013;5:214\u201326.","journal-title":"J Mol Cell Biol"},{"key":"2768_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrm2820","volume":"11","author":"JR Casey","year":"2010","unstructured":"Casey JR, Grinstein S, Orlowski J. Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol. 2010;11:50\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2768_CR55","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1021\/acs.inorgchem.7b00136","volume":"56","author":"F Navas","year":"2017","unstructured":"Navas F, Mendes F, Santos I, Navarro-Ranninger C, Cabrera S, Quiroga AG. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands. Inorg Chem. 2017;56:6175\u201383.","journal-title":"Inorg Chem"},{"key":"2768_CR56","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1093\/nar\/gkv356","volume":"43","author":"EY Chua","year":"2015","unstructured":"Chua EY, Davey GE, Chin CF, Dr\u00f6ge P, Ang WH, Davey CA. Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents. Nucleic Acids Res. 2015;43:5284\u201396.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02768-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02768-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:02:47Z","timestamp":1700406167000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02768-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2768"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02768-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Henan University. The ethics approval number is HUSOM2022-313.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of the manuscript in Journal of Experimental & Clinical Cancer Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}